Journal article · 2025
Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs)
Clinical Cancer Research, 31(12_Supplement), P1–06 · Published 13 June 2025 · DOI 10.1158/1557-3265.sabcs24-p1-06-08
In brief
“Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs)” is a 2025 journal article by Emelly Rusli and 2 co-authors, published in Clinical Cancer Research. OpenAlex counts 1 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 1
- Most cited in
- 2025 (1)
- Authors
- 3
Abstract
Background: Treatment tolerability in cancer care, historically assessed by the clinician, is moving towards incorporating patients’ voices to capture how they feel and function during treatment1-3. Women undergoing breast cancer (BC) treatment often experience debilitating symptoms and decreased quality-of-life (QoL). Routine symptom monitoring and patient-reported outcomes (PROs) may enhance the understanding of tolerability from patients’… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rusli, E., Galaznik, A., & Wujcik, D. M. (2025). Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs). Clinical Cancer Research, 31(12_Supplement), P1–06. https://doi.org/10.1158/1557-3265.sabcs24-p1-06-08
MLA 9
Rusli, Emelly, et al. “Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs).” Clinical Cancer Research, vol. 31, no. 12_Supplement, 2025, pp. P1–06. https://doi.org/10.1158/1557-3265.sabcs24-p1-06-08.
Chicago
Rusli, Emelly, Aaron Galaznik, and Debra M Wujcik. 2025. “Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs).” Clinical Cancer Research 31 (12_Supplement): P1–06. https://doi.org/10.1158/1557-3265.sabcs24-p1-06-08.
Harvard
Rusli, E., Galaznik, A. and Wujcik, D. M. (2025) ‘Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs)’, Clinical Cancer Research, 31(12_Supplement), pp. P1–06. doi:10.1158/1557-3265.sabcs24-p1-06-08.
IEEE
E. Rusli, A. Galaznik, and D. M. Wujcik, “Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs),” Clinical Cancer Research, vol. 31, no. 12_Supplement, pp. P1–06, 2025, doi: 10.1158/1557-3265.sabcs24-p1-06-08.
BibTeX
@article{rusli2025abstract,
title = {{Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs)}},
author = {Rusli, Emelly and Galaznik, Aaron and Wujcik, Debra M},
journal = {Clinical Cancer Research},
year = {2025},
volume = {31},
number = {12_Supplement},
pages = {P1--06},
doi = {10.1158/1557-3265.sabcs24-p1-06-08},
url = {https://doi.org/10.1158/1557-3265.sabcs24-p1-06-08}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- breast cancer
- treatment tolerability
- patient-reported outcomes
- remote symptom monitoring
- quality of life
- HER2-positive breast cancer
- triple-negative breast cancer
- hormone receptor-positive HER2-negative breast cancer
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Rusli, E., Galaznik, A., & Wujcik, D. M. (2025). Abstract P1-06-08: Quantifying Treatment Tolerability in Real-world Breast Cancer Practice: A Pragmatic Approach Utilizing Patient-Reported Outcomes (PROs). Clinical Cancer Research, 31(12_Supplement), P1–06. https://doi.org/10.1158/1557-3265.sabcs24-p1-06-08
How many times has this paper been cited?
1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Emelly Rusli, Aaron Galaznik, Debra M Wujcik.
What is the DOI of this paper?
10.1158/1557-3265.sabcs24-p1-06-08, permanently at https://doi.org/10.1158/1557-3265.sabcs24-p1-06-08. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.